<DOC>
	<DOCNO>NCT02313233</DOCNO>
	<brief_summary>To evaluate improvement symptom Benign Prostatic Hyperplasia ( BPH ) accord Prostate Symptom Score ( IPSS ) Quality- of- Life ( QoL ) index add- therapy Umooze twice daily administration 56 day patient BPH .</brief_summary>
	<brief_title>Research Benefit Umooze Add- Therapy Benign Prostatic Hyperplasia</brief_title>
	<detailed_description>The study product , Umooze , contain Astragalus radix extract Soy extract combination 960:40 one 500 mg tablet . Umooze sell market food . The objective study evaluate benefit Umooze add- therapy BPH , evaluation improvement symptom BPH assess accord International Prostate Symptom Score ( IPSS ) Quality- of- Life ( QoL ) index add- therapy Umooze patient BPH . The IPSS validate 7-item urinary symptom severity scale . A randomized , two-regimen , placebo-controlled , parallel- design use study subject receive Umooze placebo . The add- study product administer twice daily 56 day . Benefit evaluate baseline subsequently study day 28 , 42 , 56 , IPSS index , QoL index , Qmax , PVR , prostate volume Prostate-specific antigen ( PSA ) .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Males age &gt; =40 year old Screened inquiry diagnose BPH base result digital rectal examination ( DRE ) transrectal ultrasonography ( TRUS ) Prostate volume &gt; = 20 cm3 Has complain void symptom relate BPH Has IPSS &gt; = 13 UFR measure Qmax &lt; = 15 ml/sec together void volume &gt; = 150 ml . Serum PSA &lt; 6.5 ng/ml Has treat medication BPH Informed consent form sign . Sensitivity study product Had receive prostatic surgery BPH past 24 week Hard nodule find DRE Ongoing neurogenic bladder , urinary tract infection , bladder stone , urethral stricture , bladder cancer , prostate cancer , severe liver dysfunction , severe renal dysfunction severe cardiovascular disease . Patient clinically significant physical disability abnormal finding physical examination laboratory test judge investigator co investigator . Participation clinical investigation last 30 day . Individuals judge investigator co investigator undesirable subject .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>